Ser354

Site Information
SVHLRKAssPNLHRR SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 7445537

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 3 , 4 )
Disease tissue studied:	gastric cancer ( 3 ) , gastric carcinoma ( 3 )
Relevant cell line - cell type - tissue:	786-O (renal) [VHL (human), transfection] ( 1 ) , 786-O (renal) ( 1 ) , A498 (renal) ( 4 ) , MKN-45 (gastric) ( 3 )

References
1	Malec V, Coulson JM, Urbé S, Clague MJ (2015) Combined Analyses of the VHL and Hypoxia Signaling Axes in an Isogenic Pairing of Renal Clear Cell Carcinoma Cells. J Proteome Res 14, 5263-72 26506913 Curated Info
2	Shiromizu T, et al. (2013) Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 12, 2414-21 23312004 Curated Info
3	Mulhern D (2012) CST Curation Set: 13405; Year: 2012; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Curated Info
4	Schreiber TB, et al. (2010) An integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling. Mol Cell Proteomics 9, 1047-62 20071362 Curated Info